Kerstin Henninger

This inventor holds 26 USPTO granted patents and 2 published patent applications, plus 14 CIPO patents and 9 EPO patents, primarily in Antiviral Compounds. Top assignees: Aicuris Gmbh + Co. Kg., Bayer Aktiengesellschaft, Bayer Healthcare Aktiengesellschaft. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kerstin Henninger. Retrieved from https://idiyas.com/inventor/kerstin-henninger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 2)

% Patents Active = 53.8

CIPO Patents = 14 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 1)

Average Co-Inventor Count = 10.2

ph-index = 6

Forward Citations = 167(Granted Patents)

Company Filing History:

11 out of 53

Aicuris Gmbh + Co. Kg.

patents

4 out of 12,266

Bayer Aktiengesellschaft

patents

4 out of 77

Bayer Healthcare Aktiengesellschaft

patents

4. 3 out of 192

Bayer Schering Pharma Ag

Aicuris Anti-Infective Cures Gmbh

patents

7. 1 out of 1

Aicuris Gmbh & Co. Hk

patent

8. 1 out of 721

Bayer Intellectual Property Gmbh

patents

Years Active: 2002-2023

Loading Chart...

Areas of Expertise:

Dihydroquinazolines

Aryl Sulfonamides

Thiazoles

Pyrroles

Antiviral Agents

Quinolones

Imidazoles

Adenosine Receptor

Thiazolyl Derivatives

Pyrazolamides

Heterocycles

Antibacterial Macrocycles

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49698 - Substituted dihydroquinazolines (2023-10-17),

2. RE46791 - Substituted dihydroquinazolines (2018-04-16),

3. 8691850 - Substituted phenylaminothiazoles and use thereof (2014-04-08),

4. 8513255 - Substituted dihydroquinazolines (2013-08-20),

5. 8410090 - Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes (2013-04-02),

6. 8343981 - Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents (2013-01-01),

7. 8318761 - Substituted arylsulfonamides as antiviral agents (2012-11-27),

8. 8314113 - Substituted dihydroquinazolines II (2012-11-20),

9. 8314089 - Substituted pyrazolamides and their use (2012-11-20),

10. 8198282 - Substituted azaquinazolines having an antiviral action (2012-06-12),

11. 7977349 - Substituted quinolones III (2011-07-12),

12. 7960387 - 2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses (2011-06-14),

13. 7919489 - Heterocyclyamide-substituted imidazoles (2011-04-05),

14. 7867992 - Substituted quinolones (2011-01-11),

15. 7767704 - Antiviral 4-aminocarbonylamino-substituted imidazole compounds (2010-08-03),

Title: The Innovative Mind of Kerstin Henninger

Introduction: Kerstin Henninger, a talented inventor hailing from Wuppertal, Germany, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kerstin Henninger has recently been granted patents for his cutting-edge inventions in the areas of renewable energy technologies and sustainable materials.

Career Highlights: Throughout his illustrious career, Kerstin Henninger has demonstrated a remarkable ability to transform creative ideas into tangible solutions. His work has significantly impacted the way we approach environmental challenges and has paved the way for a more sustainable future.

Collaborations: Kerstin Henninger has collaborated with leading research institutions and universities to further his research and development efforts. His partnerships have been instrumental in bringing his innovative concepts to life and have led to successful commercialization of his inventions.

Conclusion: Kerstin Henninger's passion for innovation and his dedication to creating a positive impact on the world have solidified his reputation as a visionary inventor. His contributions continue to inspire the next generation of inventors and shape the landscape of technological advancements.

Profile summary based on public USPTO records.